Cargando…
Gut-Derived Metabolite Phenylacetylglutamine and White Matter Hyperintensities in Patients With Acute Ischemic Stroke
Background: White matter hyperintensity (WMH) burden is associated with a higher risk of ischemic stroke. Phenylacetylglutamine (PAGln) is a gut microbiota-derived metabolite that may induce cardiovascular events by activating platelets and increasing the risk of thrombosis. The relationship between...
Autores principales: | Yu, Fang, Feng, Xianjing, Li, Xi, Luo, Yunfang, Wei, Minping, Zhao, Tingting, Xia, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363199/ https://www.ncbi.nlm.nih.gov/pubmed/34393756 http://dx.doi.org/10.3389/fnagi.2021.675158 |
Ejemplares similares
-
Phenylacetylglutamine, a Novel Biomarker in Acute Ischemic Stroke
por: Yu, Fang, et al.
Publicado: (2021) -
The Impact of Intracerebral Hemorrhage on the Progression of White Matter Hyperintensity
por: Chen, Xuemei, et al.
Publicado: (2018) -
Alteration of the gut microbiota and metabolite phenylacetylglutamine in patients with severe chronic heart failure
por: Zhang, Zhendong, et al.
Publicado: (2023) -
Prognostic value of plasma phenylalanine and gut microbiota-derived metabolite phenylacetylglutamine in coronary in-stent restenosis
por: Fu, Yuan, et al.
Publicado: (2022) -
Alterations in the gut microbiome with hemorrhagic transformation in experimental stroke
por: Huang, Qin, et al.
Publicado: (2021)